LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 525,782 Value ($000) $283 Avg Close — Range —
Q4 2024
Shares 525,782 Value ($000) $337 Avg Close — Range —
Q3 2024
Shares 525,782 Value ($000) $726 Avg Close — Range —
Q2 2024
Shares 671,966 Value ($000) $974 Avg Close — Range —
Q1 2024
Shares 633,479 Value ($000) $1,413 Avg Close — Range —
Q4 2023
Shares 661,017 Value ($000) $1,282 Avg Close — Range —
Q3 2023
Shares 661,561 Value ($000) $972 Avg Close — Range —
Q2 2023
Shares 659,193 Value ($000) $2,096 Avg Close — Range —
Q1 2023
Shares 653,940 Value ($000) $1,543 Avg Close — Range —
Q4 2022
Shares 656,210 Value ($000) $2,277 Avg Close — Range —
Q3 2022
Shares 658,756 Value ($000) $4,829 Avg Close — Range —
Q2 2022
Shares 549,261 Value ($000) $3,581 Avg Close — Range —
Q1 2022
Shares 390,166 Value ($000) $1,970 Avg Close — Range —
Q4 2021
Shares 71,276 Value ($000) $552 Avg Close — Range —
Q3 2021
Shares 58,618 Value ($000) $867 Avg Close — Range —